drugset / Trial / NCT03337581
Pharmacodynamics and Pharmacokinetics of Dexmedetomidine in Pediatric
RandomizedParallel-groupQuadruple-blindPrevention
Summary
1. Acute Hemodynamic and respiratory Changes After Rapid Intravenous different doses of Dexmedetomidine in Pediatric. 2. Pharmacokinetics after a single Rapid Intravenous dose of Dexmedetomidine in Pediatric. 3. Pharmacokinetics after a single dose of Dexmedetomidine administered as a nasal spray in Pediatric.
Timeline
- Start
- 2017-10-20
- Primary completion
- 2018-12
- Completion
- 2019-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dexmedetomidine | Other / unclassified | 0.25 ug/kg | Intravenous |
| Subject | Dexmedetomidine | Other / unclassified | 0.5 ug/kg | Intravenous |
| Subject | Dexmedetomidine | Other / unclassified | 0.75 ug/kg | Intravenous |
| Subject | Dexmedetomidine | Other / unclassified | 1 ug/kg | Intravenous |
Indications
No indication recorded.